Belgium – Research and experimental development services – Long-term API stockpiling and rapid finished dose form manufacture

The Health and Digital Executive Agency (HaDEA) seeks research and development services for long-term API (Active Pharmaceutical Ingredient) stockpiling strategies and rapid manufacturing capabilities for finished pharmaceutical dose forms, valued at approximately €6 million. Eligible participants likely include pharmaceutical R&D service providers, contract manufacturers, and research institutions with demonstrated expertise in API stability, storage optimization, and accelerated production processes. This is a strategic EU health security initiative requiring technical capability in pharmaceutical development, regulatory knowledge, and industrial-scale manufacturing experience.